fashion -WSS

fashion

author：fashion 2025-09-30 17:17:18 - browse：8739

inflamed intestine on a dark blue background — biotech coverage from STAT — Adobe

What happens after you close a nearly $11 billion acquisition?

Well, for Prometheus Therapeutics’ former CEO Mark McKenna, there was a brief vacation. But within weeks of the company’s acquisition by Merck closing last June, he was thinking about ideas for the future.

Investors were floating ideas by him. McKenna discussed possibilities with his teenagers and Prometheus’ chief scientific officer. This “summer of discovery,” as McKenna called it, brought him back to the immune system. Prometheus and some other companies have been able to capitalize on creating treatments for conditions like inflammatory bowel disease and psoriasis, while arthritis medications like Humira have brought in billions of dollars in sales. But the field hadn’t quite received the same attention as missions to cure cancer.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
Next article： Smaller biotechs seek to piggyback on weight loss drug boom

hotspot

leisure time

WSS

How AI can help patients find reliable information about doctors

Results on Novartis prostate cancer therapy could expand its use

Roivant's CEO is a star, but biotech's black hole persists

American taxpayers paid $1.8 trillion in health care costs in 2022

Medicare Advantage coverage denials need scrutiny, senators say

Study suggests new cause of Down syndrome: cells linked to aging

Wikipedia

fashion

leisure time

Alkermes shareholders re

Roche drug slashes death risk in early

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Why a market frenzy over new weight loss drugs defies logic

BioMarin wins approval for gene therapy to treat hemophilia A

STAT Summit: Ending the crisis of Black deaths in the U.S.

Jerome Adams on the need for new antivirals for Covid

Study on Amgen’s bispecific immunotherapy produces positive data

New air purifier tech could be key to improving indoor air quality

JPM 2024 Review: Hope for the XBI, deals from J&J, Merck, GSK

hotspot

Male doctors called my cancer incurable. A female doctor showed it wasn't

Harvard's Jason Buenrostro wins MacArthur grant for genetics work

Boston Scientific acquires urology company Axonics for $3.7 billion

The future of Biogen: Pragmatism, ‘moonshots,’ and no Twinkies

Rune Labs, whose app tracks Parkinson's symptoms, raises $12M

Results on Novartis prostate cancer therapy could expand its use

hotspot

leisure time

hotspot

leisure time